The buprenorphine market is estimated to be valued at US$ 5526.99 Mn in 2023 and is expected to exhibit a CAGR of 14.%
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |